查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198344

窦扩张器市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

Sinus Dilation Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在本研究的预测期内，鼻窦扩张器市场预计将以 8.8% 的复合年增长率增长。

COVID-19 大流行扰乱了常规患者护理。 许多医疗机构取消了例行就诊和择期手术，并重组了医护人员，以增加和维持重症监护病房和住院床位。 这妨碍了患者的护理，尤其是慢性鼻炎患者。 患者选择了远程医疗和鼻窦相关问题的临时选择。 例如，根据 2020 年 10 月发表的题为“COVID-19 大流行对美国门诊和手术室鼻科实践的影响”的研究，在办公室环境和鼻窦手术中进行面对面的咨询和手术颅底疾病 在日本，只有 1.1% 的门诊手术室和医院手术室允许选择性病例，这对鼻科实践产生了重大影响。 因此，虽然该数据显示了 COVID-19 对市场的负面影响，但病例数下降、SARS-CoV-2 病毒对人类的长期影响以及全球大规模疫苗计划已经推动研究市场有望在研究预测期内完全恢復其增长潜力。

由于微创手术具有切口更小、疤痕更少、精度更高、并发症风险更低以及住院时间更短等优点，因此越来越受欢迎，需求也越来越大，这导致全世界的鼻窦炎负担沉重。加上预计成为推动鼻窦扩张器市场增长的关键增长因素。 例如，2021 年 12 月发表的一项题为“基于鼻窦放射学和基于症状的流行率的慢性鼻鼻窦炎在普通人群中的流行率”的研究发现，基于证据的慢性鼻鼻窦炎 (CRS) 的流行率为 3% 至 6.4% .

此外，越来越多的手术和对微创手术的需求增加预计会增加对鼻窦扩张产品的需求，这有望在研究的预测期内推动监测市场的增长。 例如，根据一项于 2021 年 7 月发表的题为“过去十年英国鼻窦手术的演变——一项观察性研究”的研究报告，在 2010 年至 2019 年期间，英国约有 89,495 人进行了内窥镜手术，并增加了 21.1%。上颌骨、额叶和蝶骨手术的整体增长。 因此，随着鼻窦相关手术数量的增加，对鼻窦扩张产品的需求有望增加，从而推动所研究市场的增长。

此外，该领域主要市场参与者在鼻窦扩张器方面的技术进步数量正在增加，这将对研究预测期内鼻窦扩张器市场的增长产生积极影响。更值得期待。 例如，在 2021 年，Intersect ENT（美国）宣布推出与 PROPEL Mini Sinus Implant 配套的新型直接输送系统。 因此，随着诸如此类的发展和创新，窦扩张器的使用预计会在未来几年增加，预计会对研究市场产生积极影响。

然而，在预测期内，鼻窦手术相关的风险、并发症以及熟练医务人员短缺等因素预计将抑制鼻窦扩张器市场的增长。

鼻窦扩张器的市场趋势

在预测期内，球囊窦扩张器预计将在产品领域占据较大的市场份额

由于慢性鼻窦炎患者对药物反应不佳，需要缓解鼻窦炎的不适和疼痛症状，因此需要一种安全有效的慢性鼻窦炎治疗方法。球囊鼻窦扩张装置的需求预计将超过预测在此期间，随着球囊扩张鼻窦手术的数量在全球范围内不断增加，调查市场也在推动增长。 这是因为球囊扩张鼻窦对鼻窦的创伤小，能有效缓解慢性鼻窦炎的症状，术后恢復快。 市场上有多种气囊鼻窦扩张器设备，包括美敦力的 NuVent 气囊鼻窦扩张系统、史赛克公司的 Audion ET 扩张系统和 Meril Life Sciences 的 Mesire 鼻窦气囊导管。

Daniel H. Lofgren 和 Carl Schermetallo 于 2021 年 12 月对球囊鼻窦整形术进行的回顾性研究发现，在过去十年中，慢性鼻窦炎 ( 使用球囊鼻窦整形术治疗 CRS 的人数显着增加。 越来越多的患者选择这种治疗方法，因为它并发症风险低、恢復快、创伤小。 因此，预计该行业在本研究的预测期内将占据很大的市场份额。

此外，在研究预测期内，进一步改进球囊窦扩张器的持续研发活动，加上技术创新和新设备的推出，预计将进一步增加对球囊窦扩张器的需求。 例如，2021 年 6 月，Intersect ENT 在美国推出了先进的 VenSure 球囊窦扩张系统以及 Cube 4D 导航系统。 VenSure 球囊和 Cube 4D 导航系统用于改善衰弱性慢性鼻窦炎 (CRS) 症状的手术中。 因此，由于上述因素，球囊窦扩张器部分预计在预测期内将占据产品部分的很大份额。

预计在预测期内北美将占很大份额

按地区划分，北美地区预计将占据鼻窦扩张器市场的很大份额。 这是由于存在强大的医疗保健基础设施、鼻窦炎和相关疾病的高负担、新产品的推出、导致鼻窦炎的风险因素负担增加，例如吸烟、慢性感冒、过敏、哮喘和头部受伤。这是由于以下因素例如 例如，根据加拿大烟草和尼古丁调查 (CTNS)。 根据 2021 年的总结结果，大约 13.3%（330 万）的 25 岁以上的加拿大人说他们吸烟，而男性（13%，170 万）和女性（12%，160 万）报告了类似的当前情况吸烟率。 因此，预计该地区的鼻窦炎负担将增加，在预测期内推动对鼻窦扩张器的需求，从而促进研究市场的增长。

在北美地区，由于鼻窦炎负担高，主要市场参与者在该国的存在，以及鼻窦炎危险因素的高负担和患病率，美国是一个巨大的研究市场。预计将采取分享。 例如，根据美国疾病控制与预防中心 (CDC) 2022 年 1 月更新，美国约有 2890 万成年人被诊断出患有鼻窦炎，约占全国成年人口总数的 11.6%。 此外，约有 270 万人前往主要疾病为鼻窦炎的诊所就诊。 因此，鼻窦炎的高负担有望成为美国鼻窦扩张器市场增长的主要驱动力。

此外，与鼻窦炎相关的吸烟和哮喘等危险因素在该国频繁发生。 此外，还有许多与鼻窦炎相关的风险因素，例如吸烟和哮喘，这些因素预计会增加鼻窦炎的负担，并推动对鼻窦扩张器的治疗需求增加。 例如，根据 2022 年 5 月在 CDC 网站上发布的国家环境卫生中心关于哮喘的报告，2020 年将有大约 2530 万人（包括儿童和成人）患有哮喘，其中 35 岁最常见于 64 岁至岁年龄组。 因此，由于上述因素，预计在预测期内美国将占据北美地区研究市场的很大份额。

鼻窦扩张器市场竞争对手分析

全球鼻窦扩张器市场竞争适中。 它由 Smith and Nephew、Johnson & Johnson Inc.、Medtronic、Meril Life Sciences Private Limited 和 Olympus Corporation 等几家主要参与者组成。 随着主要市场参与者的新设备发布、併购、合作伙伴关係和其他业务扩展活动，预计市场竞争将变得更加激烈。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 对微创手术的需求不断增长，鼻窦炎患病率不断上升
    • 鼻窦扩张装置的技术进步
  • 市场製约因素
    • 与鼻窦手术相关的风险
    • 缺乏熟练的专业人员
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（金额基础：百万美元）

  • 按产品分类
    • 球囊窦扩张器
    • 鼻窦植入物
    • 手持设备
    • 内窥镜
    • 其他产品
  • 通过方法
    • 独立的窦扩张术
    • 混合窦扩张术
  • 最终用户
    • 医院
    • 专科诊所
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Intersect ENT, Inc.
    • Johnson & Johnson
    • Medtronic Plc
    • Meril Life Sciences Private Limited
    • Olympus Corporation
    • SinuSys Corporation
    • Smith & Nephew
    • Stryker Corporation
    • Creganna
    • Dalent Medical
    • InnAccel
    • Accurate Surgical & Scientific Instruments

第7章 市场机会与今后动向

简介目录
Product Code: 67153

The sinus dilation market is expected to register a CAGR of 8.8% during the forecast period of the study.

The COVID-19 pandemic led to interruptions in routine patient care. Many healthcare organizations have canceled routine clinic visits and elective surgeries to increase and maintain the availability of intensive care and inpatient care beds and have reorganized medical and nursing staff. This has particularly interrupted care for patients with chronic rhinitis. The patients opted for teleconsultations and temporary options for sinus-related problems. For instance, according to a research study published in October 2020, titled "Impact of COVID-19 Pandemic on Ambulatory and Operating Room Rhinology Practice in the US", there was a significant impact of COVID-19 on rhinology practice as the number of in-person care in the office environment and surgical management of sino-nasal and skull base illness has dramatically decreased, with only 1.1% of ambulatory surgery center/hospital operating rooms were allowing elective cases in the country. Hence, this data shows a negative impact of COVID-19 on the market, however, with the decreasing number of cases, long-term impact of SARS-CoV-2 virus on humans, and large-scale vaccination programs around the world, the studied market is expected to regain its full growth potential over the forecast period of the study.

The increasing popularity and demand for minimally invasive surgeries owing to its benefits such as smaller incisions, less scarring, high accuracy and decreased risk of complications, shorter hospital stays, and others, coupled with the high burden of sinusitis around the world are expected to be significant growth factors that are fueling growth in the sinus dilation devices market. For instance, according to the research study published in December 2021, titled "Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology", the prevalence of clinically based chronic rhinosinusitis (CRS) was 3% to 6.4%.

Further, with the growing number of surgeries and increasing demand for minimally invasive surgical procedures, the demand for sinus dilation products is expected to increase which will boost growth in the studied market over the forecast period of the study. For instance, according to a research study published in July 2021, titled "The evolution of sinus surgery in England in the last decade - An observational study", in England, between 2010 and 2019, about 89,495 sinus procedures were performed, with 21.1% increase in the endoscopic surgeries and overall increase in the maxillary, frontal and sphenoid sinus procedures. Hence, with the rising number of sinus-related surgeries, the demand for sinus dilation products is expected to increase which is expected to fuel growth in the studied market.

Additionally, a growing number of technological advancements in sinus dilation devices by the key market players in the area are further expected to have a positive impact on the growth of the sinus dilation devices market during the forecast period of the study. For example, in 2021, Intersect ENT (US) announced the launch of the new Straight Delivery System packaged with the PROPEL Mini Sinus Implant. Therefore, with developments and innovations like these, the use of sinus dilation devices is expected to increase over the years which is anticipated to have a positive impact on the studied market.

However, factors such as risks, complications associated with sinus surgeries, and lack of skilled healthcare professionals are expected to restrain the growth of the sinus dilation devices market during the forecast period.

Sinus Dilation Devices Market Trends

Balloon Sinus Dilation Device is Expected to Hold Significant Market Share in the Product Segment During Forecast Period

Patients with chronic sinusitis who are not responding well to medication and need relief from uncomfortable and painful sinusitis symptoms can benefit from the balloon sinus dilation procedure which is a safe and effective procedure for chronic sinusitis and there are several other advantages of balloon sinus dilation due to which the number of balloon sinus dilation procedures is increasing around the world and thus, the demand for balloon sinus dilation devices is expected to increase over the forecast period and driving growth in the studied market. For example, it is a less invasive procedure, effective at relieving symptoms of chronic sinusitis, faster post-operative recovery time, and others. There are several balloon sinus dilation devices available in the market such as the NuVent balloon sinus dilation system from Medtronic, Audion ET dilation system from Stryker Corporation, Mesire Sinus Balloon Catheter from Meril Life Sciences, among many others.

According to a review study published by Daniel H. Lofgren and Carl Shermetaro in December 2021 on balloon sinuplasty, over the past ten years, the use of balloon sinuplasty for the treatment of chronic rhinosinusitis (CRS) that is resistant to conventional medical therapy has significantly increased. The number of patients choosing to undergo this procedure is increasing because of its decreased risk of complications, quicker recovery time, and minimally invasive nature. Hence, this segment is expected to have a significant market share during the forecast period of the study.

Moreover, the ongoing research and development activities on further improving the balloon sinus dilation devices coupled with the technological innovations and launch of new devices are further expected to boost the demand for balloon sinus dilation devices during the forecast period of the study. For instance, in June 2021, Intersect ENT launched an advanced VenSure balloon sinus dilation system along with Cube 4D navigation system in the United States. The VenSure Balloon and Cube 4D Navigation Systems are used in procedures that are designed to improve debilitating chronic rhinosinusitis (CRS) symptoms. Therefore, due to the above-mentioned factors, the balloon sinus dilation devices segment is expected to hold a significant share in the product segment over the forecast period.

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

By geography, the North American region is expected to occupy a significant share in the sinus dilation devices market due to the factors such as the presence of robust healthcare infrastructure, high burden of sinusitis and related diseases, the launch of new products, and increased burden of risks factors causing sinusitis in the region such as smoking, chronic cold, allergies, asthma, head injury, and other factors. For instance, according to the Canadian Tobacco and Nicotine Survey (CTNS): Summary of Results for 2021, approximately 13.3% (3.3 million) of Canadian people aged 25 and over reported smoking cigarettes, and men (13% or 1.7 million) and women (12% or 1.6 million) both reported a similar level of current smoking prevalence. Hence, the burden of sinusitis is expected to increase in the region, driving demand for sinus dilation devices over the forecast period and boosting growth in the studied market.

In the North American region, the United States is expected to hold a significant market share in the studied market owing to the high burden of sinusitis, the presence of some of the key market players in the country, and the high burden and prevalence of risk factors for sinusitis. For instance, according to the January 2022 update of the Centers for Disease Control and Prevention (CDC), about 28.9 million adults in the United States are diagnosed with sinusitis which is about 11.6% of the total adult population of the country. Further, as per the same source, about 2.7 million visits are made to physician offices with chronic sinusitis as the primary diagnosis in the country. Thus, the high burden of sinusitis is expected to be the major driving factor for the growth of the sinus dilation devices market in the United States.

Further, the risk factors associated with sinusitis such as smoking and asthma, are highly prevalent in the country. They are further expected to increase the burden of sinusitis in the country and thus, fuel growth in the demand for sinus dilation devices for their treatment. For instance, according to the National Center for Environmental Health's report on asthma published in May 2022 on CDC's website, about 25.3 million people (children and adults both) had asthma in 2020 and it was most prevalent among the age group of 35-64 years. Therefore, owing to the factors mentioned above, the United States is expected to hold a significant share in the studied market in the North American region over the forecast period.

Sinus Dilation Devices Market Competitor Analysis

The global sinus dilation devices market is moderately competitive. It comprises several significant players such as Smith and Nephew, Johnson & Johnson Inc., Medtronic, Meril Life Sciences Private Limited, and Olympus Corporation, among many others. The market is expected to grow more competitive with the launch of new devices, mergers and acquisitions, partnerships and other business expansion activities by the key market players.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Minimally Invasive Procedures and Increasing Prevalnce of Sinusitis
    • 4.2.2 Technological Advancements in Sinus Dilation Devices
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Sinus Surgeries
    • 4.3.2 Lack of Skilled Specialists
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value in USD Million)

  • 5.1 By Product
    • 5.1.1 Balloon Sinus Dilation Devices
    • 5.1.2 Sinus Implants
    • 5.1.3 Handheld Instruments
    • 5.1.4 Endoscopes
    • 5.1.5 Other Products
  • 5.2 By Procedure
    • 5.2.1 Standalone Sinus Dilation Procedures
    • 5.2.2 Hybrid Sinus Dilation Procedures
  • 5.3 By End-User
    • 5.3.1 Hospital
    • 5.3.2 Specialty Clinic
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Intersect ENT, Inc.
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Medtronic Plc
    • 6.1.4 Meril Life Sciences Private Limited
    • 6.1.5 Olympus Corporation
    • 6.1.6 SinuSys Corporation
    • 6.1.7 Smith & Nephew
    • 6.1.8 Stryker Corporation
    • 6.1.9 Creganna
    • 6.1.10 Dalent Medical
    • 6.1.11 InnAccel
    • 6.1.12 Accurate Surgical & Scientific Instruments

7 MARKET OPPORTUNITIES AND FUTURE TRENDS